Robust revenue growth of the global water-soluble drugs market is attributed to factors such as rising prevalence of chronic and acute illnesses, increasing pharmaceutical research & development activities, rising focus on novel drug discovery & development, and increasing government investments in the life sciences industry.
Emergen Research has published its latest report titled “Water-soluble Drugs Market, By Drug Type (Paracetamol, Antibiotics, Antihypertensive Drugs), By Route of Administration (Oral, Intravenous Injection), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers, Rehabilitation Centers, Homecare Settings, Others), and By Region, Forecast to 2028”
Market Dynamics:
Robust revenue growth of the global water-soluble drugs market is attributed to factors such as rising prevalence of chronic and acute illnesses, increasing pharmaceutical research & development activities, rising focus on novel drug discovery & development, and increasing government investments in the life sciences industry. Rising awareness of the various advantages associated with water-soluble drugs, growing use of water-soluble drugs in liquid pharmaceutical formulations, rapid development of bioequivalent drugs, and increasing focus of pharmaceutical companies on enhancing drug solubility are among the major factors expected to boost revenue growth of the global market.
When it comes to pharmacokinetics and pharmacodynamics of a drug, water solubility is one of the most critical parameters to be considered. Water-soluble drugs are capable of dissolving completely in water, and these drugs stay in the bloodstream for a longer period. Other key advantages of these drugs include high solubility, limited side-effects, and increased bioavailability and effectiveness. These drugs are more suitable for systemic circulation and generate a positive pharmacological response. However, water-soluble drugs are excreted faster and have lower tissue permeability as compared to lipid-soluble drugs. This is a key factor expected to restrain market revenue growth over the forecast period.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/289
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Oral Route of Administration Segment Accounted for Largest Revenue Share in 2019:
Based on route of administration, the global water-soluble drugs market is segmented into oral and intravenous injection. The oral segment was the most dominant in terms of largest revenue share in the global market in 2020. Oral route of drug administration is the most convenient mode of drug administration due to certain advantages including ease of administration, higher cost-effectiveness, and better patient compliances.
Antibiotics Drug Type Segment to Account for Fastest Revenue CAGR:
Based on drug type, the global water-soluble drugs market is segmented into paracetamol, antibiotics, and antihypertensive drugs. The antibiotics segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Major factors expected to boost this segment’s revenue growth are rising cases of infectious diseases, including the novel coronavirus disease, around the world, and growing demand for antibiotic drugs due to various advantages such as improved efficacy, high bioavailability, and desired response.
North America Accounted for Largest Revenue Share:
Among regional markets, the North America water-soluble drugs market was the most dominant in terms of largest revenue share in the global market in 2020. Key factors supporting the regional market revenue growth are rising focus of pharmaceutical companies on enhancing the water solubility of specific drugs, increased use of water-soluble drugs in liquid drug formulations, increasing research & development activities in the pharmaceutical industry, and introduction of innovative drug designing technologies.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/289
Major Companies in the Global Water-soluble Drugs Market Include:
- Cipla Limited
- Pfizer, Inc.
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson
- GlaxoSmithKline PLC
- Sanofi Pasteur SA
- Emergent Biosolutions, Inc.
- Novartis
- Thermo Fisher Scientific
- Biogen Inc.
- F. Hoffman-La Roche Ltd.
For the purpose of this report, Emergen Research has segmented the global water-soluble drugs market on the basis of drug type, route of administration, end-use, and region:
Drug Type Outlook (Revenue, USD Million; 2018-2028)
- Paracetamol
- Antibiotics
- Antihypertensive Drugs
Route of Administration Outlook (Revenue, USD Million; 2018-2028))
- Oral
- Intravenous Injection
End-use Outlook (Revenue, USD Million; 2018-2028))
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Rehabilitation Centers
- Homecare Settings
- Others
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/water-soluble-drugs-market
Region Outlook (Revenue, USD Million; 2018-2028))
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Explore Similar Reports offered by Emergen Research:
The Global Medical Supplies Market size was valued at USD 126.57 Billion in 2019 and is anticipated to reach USD 180.89 Billion by 2027 at a CAGR of 4.5%. A rapid increase in chronic diseases due to the unhealthy lifestyle is a major factor propelling the demand for the medical supplies market.
The Global Industrial Microbiology Market size was valued at USD 10.80 Billion in 2019 and is expected to reach USD 17.71 Billion by 2027 at a CAGR of 6.8%. The global industrial microbiology market is anticipated to grow exponentially over the forecasted timeline due to the rising demand for microbial applications and vaccines’ development.
The Global Blockchain in Genomics Market size was valued at USD 24.5 Million in 2019 and is anticipated to reach USD 1,258.3 Million by 2027 at a CAGR of 65.8%. The global market for blockchain in genomics is likely to grow significantly, owing to the increasing demand for data security of unique genomic data.
The global nanopharmaceutical drugs market size was valued at USD 46.90 Billion in 2019 and is forecasted to reach USD 82.71 Billion by 2027 at a CAGR of 7.3%. The nanopharmaceutical drugs market is observing high demand attributed to its increasing application in oncology, cardiovascular/physiology, anti-inflammatory/immunology, neurology, and anti-biotic.
The global clinical perinatal software market size was valued at USD 212.6 Million in 2019 and is forecasted to reach USD 393.3 Million by 2027 at a CAGR of 7.9%. The clinical perinatal software market is observing high demand attributed to its increasing application in workflow management, fetal monitor data services, and patient documentation.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services